Papaverine and hepatotoxicity
- PMID: 7003573
- PMCID: PMC2425822
- DOI: 10.1136/pgmj.56.657.488
Papaverine and hepatotoxicity
Abstract
Six of 14 patients receiving a sustained release papaverine preparation developed abnormal liver function tests. One patient had jaundice and another abnormal liver histology on a biopsy specimen. This is only the third report of impaired liver function following the administration of papaverine--a drug which has been used in clinical medicine for over 100 years.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical